Consumer stories: Switching from nicotine to flavoured inhalers
By Carsten Leonhard Knudsen, Considaret Clk Group Denmark, Vave Pharma & Go Global International ApS, Danmark
Habits rarely disappear overnight. They linger, change shape, adapt to new routines. For many smokers, the act of quitting nicotine isn’t just a physical battle—it’s behavioral, emotional, even social. And in that transition, people search for something to hold onto. Not necessarily another chemical, but a gesture, a moment, a pause that replaces the old one.
That’s where we’ve seen an interesting shift: flavoured, nicotine-free inhalers. Specifically, the kind that Vave Pharma produces—aromatic, smoke-free, and subtle.
Let me tell you a few stories.
A woman in Aarhus, mid-thirties, had been smoking since university. She’d tried patches, cold turkey, herbal cigarettes. None of it stuck. What worked, oddly enough, was an inhaler that smelled like mint and eucalyptus. Not because it erased cravings entirely, but because it gave her something else to reach for during moments of tension. Her words were something like, "It didn’t feel like quitting. It felt like switching."
In Copenhagen, a design firm quietly placed a bowl of sample inhalers in their break room. No labels, no instructions. Just curiosity. Over the weeks, people started using them during brainstorming sessions. Not smokers, necessarily. But those looking for a mental pause. A way to reset without caffeine or distraction. Eventually, the bowls had to be refilled twice a week.
And then there’s the older gentleman—retired, long-time pipe smoker. He said he didn’t care about trends, but when his granddaughter brought home a cinnamon-scented inhaler, he was intrigued. Today, he keeps one in his coat pocket. Just in case.
These are anecdotal stories, yes. But sometimes anecdotes are where the real data lives.
Behavioral change doesn’t always follow a linear path. For many, quitting nicotine isn’t about going from A to B. It’s about creating a series of small bridges. Inhalers like ours aren’t medical devices. We don’t claim to cure addiction. But they do offer an option. A healthier interruption. Something that feels familiar without being harmful.
The success of these products, I believe, lies in their lack of pressure. They don’t tell the user what to do. They invite a shift. That’s a crucial difference.
At Vave Pharma, we pay close attention to the user experience. The texture, weight, and draw resistance of each inhaler is intentional. We’ve found that the feel matters as much as the aroma. If it doesn’t feel satisfying in the hand or in use, it won’t stick.
We’re also constantly asking questions. What kinds of flavors comfort people? Which ones energize? How does scent connect with memory or stress management? These aren’t just technical questions. They’re human ones.
From our base in Danmark, under Considaret Clk Group Denmark and in collaboration with Go Global International ApS, we’ve taken a quiet approach. No bold promises. Just careful product design, consumer empathy, and transparency. That combination seems to be resonating. Enough so that our work has led us to be nominated for the 2025 Go Global Awards in London, hosted this November by the International Trade Council. It’s not just an award event. It’s a convergence. A gathering of global thinkers, builders, and optimists. To be part of that community—to contribute to that conversation—is a privilege we don’t take lightly.
Looking ahead, we’re exploring deeper personalization: inhalers tailored to specific moods, time of day, even seasonal effects. We’re working with designers, scent experts, and behavioral researchers to understand what makes these small objects so impactful.
In the end, it might come down to something simple. People don’t just want to quit. They want to evolve. They want options that feel like their own. If a cinnamon-scented inhaler helps someone take one step away from nicotine, or even just find a moment of calm, then it’s doing its job.
And maybe, just maybe, that's enough.
